Matches in SemOpenAlex for { <https://semopenalex.org/work/W3098492729> ?p ?o ?g. }
- W3098492729 endingPage "3266" @default.
- W3098492729 startingPage "3248" @default.
- W3098492729 abstract "Primary bone tumor, also known as osteosarcoma (OS), is the most common primary malignancy of bone in children and young adults. Current treatment protocols yield a 5-year survival rate of near 70% although approximately 80% of patients have metastatic disease at the time of diagnosis. However, long-term survival rates have remained virtually unchanged for nearly four decades, largely due to our limited understanding of the disease process. One major signaling pathway that has been implicated in human OS tumorigenesis is the insulin-like growth factor (IGF)/insulin-like growth factor-1 receptor (IGF1R) signaling axis. IGF1R is a heterotetrameric α2β2 receptor, in which the α subunits comprise the ligand binding site, whereas the β subunits are transmembrane proteins containing intracellular tyrosine kinase domains. Although numerous strategies have been devised to target IGF/IGF1R axis, most of them have failed in clinical trials due to the lack of specificity and/or limited efficacy. Here, we investigated whether a more effective and specific blockade of IGF1R activity in human OS cells can be accomplished by employing dominant-negative IGF1R (dnIGF1R) mutants. We engineered the recombinant adenoviruses expressing two IGF1R mutants derived from the α (aa 1-524) and β (aa 741-936) subunits, and found that either dnIGF1Rα and/or dnIGF1Rβ effectively inhibited cell migration, colony formation, and cell cycle progression of human OS cells, which could be reversed by exogenous IGF1. Furthermore, dnIGF1Rα and/or dnIGF1Rβ inhibited OS xenograft tumor growth in vivo, with the greatest inhibition of tumor growth shown by dnIGF1Rα. Mechanistically, the dnIGF1R mutants down-regulated the expression of PI3K/AKT and RAS/RAF/MAPK, BCL2, Cyclin D1 and most EMT regulators, while up-regulating pro-apoptotic genes in human OS cells. Collectively, these findings strongly suggest that the dnIGF1R mutants, especially dnIGF1Rα, may be further developed as novel anticancer agents that target IGF signaling axis with high specificity and efficacy." @default.
- W3098492729 created "2020-11-23" @default.
- W3098492729 creator A5006742120 @default.
- W3098492729 creator A5007210149 @default.
- W3098492729 creator A5013120307 @default.
- W3098492729 creator A5016567181 @default.
- W3098492729 creator A5016583883 @default.
- W3098492729 creator A5017941291 @default.
- W3098492729 creator A5019749560 @default.
- W3098492729 creator A5022987025 @default.
- W3098492729 creator A5035674811 @default.
- W3098492729 creator A5040470251 @default.
- W3098492729 creator A5047289105 @default.
- W3098492729 creator A5050688085 @default.
- W3098492729 creator A5052760599 @default.
- W3098492729 creator A5058661277 @default.
- W3098492729 creator A5060775825 @default.
- W3098492729 creator A5062670552 @default.
- W3098492729 creator A5065544513 @default.
- W3098492729 creator A5070578608 @default.
- W3098492729 creator A5076398160 @default.
- W3098492729 creator A5079286604 @default.
- W3098492729 creator A5086690723 @default.
- W3098492729 creator A5090414746 @default.
- W3098492729 date "2020-01-01" @default.
- W3098492729 modified "2023-10-16" @default.
- W3098492729 title "Blockade of IGF/IGF-1R signaling axis with soluble IGF-1R mutants suppresses the cell proliferation and tumor growth of human osteosarcoma." @default.
- W3098492729 cites W1543052044 @default.
- W3098492729 cites W1595424043 @default.
- W3098492729 cites W1820805004 @default.
- W3098492729 cites W1835811038 @default.
- W3098492729 cites W1900399885 @default.
- W3098492729 cites W1967433667 @default.
- W3098492729 cites W1968051919 @default.
- W3098492729 cites W1971475600 @default.
- W3098492729 cites W1999030960 @default.
- W3098492729 cites W2001205379 @default.
- W3098492729 cites W2004736524 @default.
- W3098492729 cites W2010399667 @default.
- W3098492729 cites W2013687141 @default.
- W3098492729 cites W2019356007 @default.
- W3098492729 cites W2022936070 @default.
- W3098492729 cites W2023292535 @default.
- W3098492729 cites W2025373202 @default.
- W3098492729 cites W2030204681 @default.
- W3098492729 cites W2032855363 @default.
- W3098492729 cites W2033707323 @default.
- W3098492729 cites W2042851200 @default.
- W3098492729 cites W2047724495 @default.
- W3098492729 cites W2050592402 @default.
- W3098492729 cites W2059641782 @default.
- W3098492729 cites W2067713829 @default.
- W3098492729 cites W2072194939 @default.
- W3098492729 cites W2072755256 @default.
- W3098492729 cites W2074111028 @default.
- W3098492729 cites W2075642848 @default.
- W3098492729 cites W2076133821 @default.
- W3098492729 cites W2084016524 @default.
- W3098492729 cites W2091920265 @default.
- W3098492729 cites W2094134393 @default.
- W3098492729 cites W2097190244 @default.
- W3098492729 cites W2109600717 @default.
- W3098492729 cites W2119122462 @default.
- W3098492729 cites W2120166815 @default.
- W3098492729 cites W2120927552 @default.
- W3098492729 cites W2121635154 @default.
- W3098492729 cites W2123187034 @default.
- W3098492729 cites W2123845167 @default.
- W3098492729 cites W2132861513 @default.
- W3098492729 cites W2141398932 @default.
- W3098492729 cites W2145335139 @default.
- W3098492729 cites W2147188402 @default.
- W3098492729 cites W2155927815 @default.
- W3098492729 cites W2160466713 @default.
- W3098492729 cites W2162098634 @default.
- W3098492729 cites W2163833439 @default.
- W3098492729 cites W2195407532 @default.
- W3098492729 cites W2198846739 @default.
- W3098492729 cites W2255582474 @default.
- W3098492729 cites W2335158284 @default.
- W3098492729 cites W2338107694 @default.
- W3098492729 cites W2396850828 @default.
- W3098492729 cites W2411216265 @default.
- W3098492729 cites W2435092580 @default.
- W3098492729 cites W2475666993 @default.
- W3098492729 cites W2539142011 @default.
- W3098492729 cites W2573710850 @default.
- W3098492729 cites W2590535959 @default.
- W3098492729 cites W2605112064 @default.
- W3098492729 cites W2605187236 @default.
- W3098492729 cites W2608335129 @default.
- W3098492729 cites W2610927159 @default.
- W3098492729 cites W2611706138 @default.
- W3098492729 cites W2731203748 @default.
- W3098492729 cites W2752358357 @default.
- W3098492729 cites W2765842953 @default.
- W3098492729 cites W2769196075 @default.
- W3098492729 cites W2773289102 @default.